Continuous Improvement in Financial Results
Ascent reported its third consecutive quarter of financial improvement, driven by effective stabilization efforts and internal self-help initiatives.
Operational Efficiency and Cost Reduction
The company achieved significant cost reductions and operational efficiencies, leading to improved margins and profitability.
Specialty Chemicals Segment Performance
The Specialty Chemicals segment reported a 67% year-over-year improvement in gross margin and a 30% gain in average sales price versus Q2.
Improvement in Gross Profit and Margin
Gross profit increased 117% to $6.5 million, with a gross margin increase to 15.1% from 6.4% in the prior year period.
Adjusted EBITDA Improvement
Adjusted EBITDA increased to $2.5 million from negative $1.5 million in the same period last year, with an improved margin of 5.7%.
Strong Liquidity Position
Ascent remains debt-free with $8.5 million in cash and access to $57.5 million in borrowing availability.